ProfileGDS5822 / ILMN_2764380
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 3% 47% 0% 5% 7% 22% 20% 13% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16.83
GSM1276600PDAC Late Ablation Control 222.747
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 12.20
GSM1276603PDAC Late Ablation 25.85
GSM1276604PDAC Late Ablation 36.77
GSM1303940PDAC Late Ablation_anti-CTLA4 113.422
GSM1303941PDAC Late Ablation_anti-CTLA4 210.720
GSM1303942PDAC Late Ablation_anti-CTLA4 37.913